Infographic: Glucose Monitor and Insulin Pump Markets To Reach A Combined $17.9Bn By 2023
The markets for glucose monitors and insulin pumps together have a four-year growth rate of over 12%, with the US markets expanding at a combined rate of 17.5% per year, according to the Meddevicetracker Dashboard.
You may also be interested in...
Approval for Boston Scientific’s TheraSphere offers further access to the therapy that, until now, has only been available under a humanitarian device exemption.
The UK-based company is seeking to raise a further $100m in 2021 following the recent US clearance of its first product, a daytime-use neurostimulation device for snoring and mild obstructive sleep apnea.
The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.